The radionuclides released during the accident at the Fukushima Daichii nuclear power plant following the Tōhoku earthquake and tsunami on 11 March 2011 were dispersed in the whole north hemisphere. Traces of (131)I, (134)Cs and (137)Cs reached Greece and were detected in air, grass, sheep milk, ground deposition, rainwater and drainage water. Members of Six Greek laboratories of the national network for environmental radioactivity monitoring have collaborated with the Greek Atomic Energy Commission (GAEC) and carried out measurements during the time period between 11 March 2011 and 10 May 2011 and reported their results to GAEC. These laboratories are sited in three Greek cities, Athens, Thessaloniki and Ioannina, covering a large part of the Greek territory. The concentrations of the radionuclides were studied as a function of time. The first indication for the arrival of the radionuclides in Greece originating from Fukushima accident took place on 24 March 2011. After 28 April 2011', concentrations of all the radionuclides were below the minimum detectable activities (<10 μBq m(-3) for (131)I). The range of concentration values in aerosol particles was 10-520 μBq m(-3) for (131)I, 10-200 μBq m(-3) for (134)Cs and 10-200 μBq m(-3) for (137)Cs and was 10-2200 μBq m(-3) for (131)I in gaseous phase. The ratios of (131)I/(137)Cs and (134)Cs/(137)Cs concentrations are also presented. For (131)I, the maximum concentration detected in grass was 2.2 Bq kg(-1). In the case of sheep milk, the maximum concentration detected for (131)I was 2 Bq l(-1). Furthermore, more than 200 samples of imported foodstuff have been measured in Greece, following the EC directives on the inspection of food and feeding stuffs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/rpd/nct094 | DOI Listing |
Asian Pac J Cancer Prev
January 2025
Research Center for Noncommunicable Disease, Jahrom University of Medical Sciences, Jahrom, Iran.
Background: Breast cancer (BC) is a global challenge that affects a large portion of individuals, especially women. It has been suggested that microparticles (MPs) can be used as a diagnostic, prognostic, or therapeutic biomarker in various diseases. Moreover, MPs are known to elevate in cancer cases.
View Article and Find Full Text PDFEchocardiography
February 2025
Department of Cardiology, MedStar Georgetown University Hospital, Washington, DC, USA.
Objective: This study evaluated the safety and efficacy of isoproterenol administration as an adjunct for achievement of target heart rate (HR) during dobutamine stress echocardiography (DSE).
Background: In DSE, optimal accuracy is achieved when a target HR of 85% of maximal predicted heart rate (MPHR) is attained. Although rarely studied, intravenous isoproterenol has been used as an adjunct therapy to dobutamine and atropine to increase chronotropic response during pharmacologic stress testing.
Acta Neuropathol Commun
January 2025
Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.
Deposition of abnormally phosphorylated tau aggregates is a central event leading to neuronal dysfunction and death in Alzheimer's disease (AD) and other tauopathies. Among tau aggregates, oligomers (TauOs) are considered the most toxic. AD brains show significant increase in TauOs compared to healthy controls, their concentration correlating with the severity of cognitive deficits and disease progression.
View Article and Find Full Text PDF: The chronic kidney disease (CKD) burden in the US varies by race/ethnicity. It was unclear whether nativity status influences these disparities. This study compared CKD prevalence by nativity status, race and ethnicity, and length of US residence.
View Article and Find Full Text PDFJ Ayurveda Integr Med
January 2025
Bharatiya Sanskriti Darshan Trust's Integrated Cancer Treatment and Research Centre, Wagholi, Pune, 412 207, Maharashtra, India.
Introduction: Male breast cancer (MBC) is an uncommon malignancy. In spite of conventional Allopathic treatment, long-term disease-free survival (DFS) of more than 10 years in MBC is rare, due to its aggressive nature.
Case Presentation: We report a case of 56 years old, stage IIB and grade III invasive ductal cell carcinoma MBC (Lt) patient, operated for left modified radical mastectomy with axillary clearance followed by six cycles of chemotherapy during October 2010-January 2011.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!